Alan Knuckman

Analyst Articles

Pharmaceuticals are getting attention with the Affordable Care Act ruling from the Supreme Court today.  For pharma companies that sell cheap, generic drugs the ruling does not matter — they’ll see continue demand. Now that the Affordable Care Act has been upheld, Teva Pharmeceuticals (… Read More

One of the main advantages of buying options is absolute financial risk.  The potential for gain is unlimited, but long option buyers can rest easy with the knowledge that the worst that can happen is the premium going to zero.  … Read More

The pre Fourth of July holiday week saw stocks rally off key support. The five session gains in excess of 5% for the major stock indexes marked the biggest weekly advance in two years. The bottoming potential at March lows reversed stocks with conviction. Read More

Sometimes the talking heads and pundits in the media don’t let facts get in the way of the financial narrative they want. Their daily drive for drama intentionally plays on traders’ emotions for audience ratings. Watching, listening or reading the often-misguided over-analysis of happenings that drive markets is entertainment designed… Read More